SCHEMBL9584502

SCHEMBL9584502

CC(C)C(=O)OC(OCCCO)n1cnc2c(N)nc(N)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 8/20 0.49
▸ CDK2 P24941 8/20 0.49
▸ CCNB1 P14635 6/20 0.49
▸ CCNE1 P24864 5/20 0.49
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ PRKACA P17612 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ PRKACG P22612 1/20 0.35
▸ PRKACB P22694 1/20 0.35
▸ MAPK3 P27361 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CCNA1 P78396 1/20 0.35
▸ HINT1 P49773 1/20 0.35
▸ CDC20 Q12834 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ AHCY P23526 1/20 0.33
▸ HSP90B1 P14625 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9583170 0.82 CDK1 (0.47) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9594480 0.80 HK1 (0.43) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9584791 0.80 CDK1 (0.54) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9583081 0.80 CDK1 (0.44) CDK1CDK2CCNB1CCNE1HDAC1
Ammonia Solution, Strong SCHEMBL10907044 0.79 CDK1 (0.52) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9583423 0.78 HDAC1 (0.37) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9583879 0.78 ADORA2A (0.48) AHCY
SCHEMBL9917839 0.77 CDK1 (0.51) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL9584828 0.76 CCNB2 (0.40) CDK1CCNB1AHCYCCNB2CCNB3
SCHEMBL9584895 0.75 HK1 (0.41) CDK1CDK2CCNB1CCNE1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback